Upstream Bio, Inc. UPB

Updated: 17 Jun 2026

NASDAQ | Biotech | Biotech, inflammatory diseases

No signal published yet

We already track Upstream Bio and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Upstream Bio free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotech, inflammatory diseases
We're already tracking Upstream Bio, Inc. — here are the latest events we've registered

Recent News

  • On June 14, 2026, the company announced new Phase 2 data for verekitug demonstrating clinically meaningful improvements in patients with chronic rhinosinusitis with nasal polyps. The results, presented at the EAACI 2026 Congress, showed significant reductions in nasal polyp scores and high responder rates.

What Firelda Watch includes for Upstream Bio, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Upstream Bio, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow Upstream Bio, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Upstream Bio free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Upstream Bio, Inc. UPB
Upstream Bio — follow and we'll monitor it
Follow Upstream Bio free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.